1. Home
  2. RDCM vs TKNO Comparison

RDCM vs TKNO Comparison

Compare RDCM & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Radcom Ltd.

RDCM

Radcom Ltd.

HOLD

Current Price

$13.70

Market Cap

215.2M

Sector

Technology

ML Signal

HOLD

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

HOLD

Current Price

$4.62

Market Cap

236.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDCM
TKNO
Founded
1985
1996
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
215.2M
236.6M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
RDCM
TKNO
Price
$13.70
$4.62
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$18.00
N/A
AVG Volume (30 Days)
88.7K
150.1K
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
37.57
N/A
EPS
0.64
N/A
Revenue
$68,901,000.00
$39,801,000.00
Revenue This Year
$18.86
$8.79
Revenue Next Year
$11.39
$10.52
P/E Ratio
$21.86
N/A
Revenue Growth
17.27
9.50
52 Week Low
$9.88
$3.94
52 Week High
$15.98
$10.37

Technical Indicators

Market Signals
Indicator
RDCM
TKNO
Relative Strength Index (RSI) 59.24 46.96
Support Level $12.69 $4.53
Resistance Level $13.14 $4.87
Average True Range (ATR) 0.43 0.28
MACD 0.15 0.04
Stochastic Oscillator 79.80 64.79

Price Performance

Historical Comparison
RDCM
TKNO

About RDCM Radcom Ltd.

Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Share on Social Networks: